The effects of quinestrol and bromocriptine on blood coagulation, serum prolactin and serum FSH levels in puerperal women. 1978

G K Osbourne, and K A Whigham, and P W Howie, and P England, and A Kelly, and C R Prentice

The effects of bromocriptine and quinestrol upon coagulation and fibrinolysis during the puerperium were studied. Quinestrol therapy was associated with increased levels of factors VII and IX and decreased antithrombin activity on the sixth postpartum day, and increased factor IX and plasminogen levels on the fourteenth postpartum day. Six weeks after delivery elevated levels of factors II and VII and of plasminogen were recorded in women given quinestrol. Bromocriptine therapy only caused an increase in the level of factor IX at six weeks after delivery. Compared to controls, patients given bromocriptine had lower prolactin and higher FSH levels during the puerperium whereas the patients given quinestrol had increased prolactin levels and a late fall in FSH levels.

UI MeSH Term Description Entries
D009651 Norpregnatrienes Pregnatrienes which have undergone ring contractions or are lacking carbon-18 or carbon-19.
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011800 Quinestrol The 3-cyclopentyl ether of ETHINYL ESTRADIOL. After gastrointestinal absorption, it is stored in ADIPOSE TISSUE, slowly released, and metabolized principally to the parent compound. It has been used in ESTROGEN REPLACEMENT THERAPY. (From AMA Drug Evaluations Annual, 1992, p1011) Ethinyl Estradiol 3-Cyclopentyl Ether,Estrovis,Ethinyl Estradiol 3 Cyclopentyl Ether
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D001971 Bromocriptine A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion. 2-Bromoergocryptine,Bromocryptin,2-Bromo-alpha-ergocryptine,2-Bromo-alpha-ergokryptine,2-Bromoergocryptine Mesylate,2-Bromoergocryptine Methanesulfonate,2-Bromoergokryptine,Bromocriptin,Bromocriptine Mesylate,CB-154,Parlodel,2 Bromo alpha ergocryptine,2 Bromo alpha ergokryptine,2 Bromoergocryptine,2 Bromoergocryptine Mesylate,2 Bromoergocryptine Methanesulfonate,2 Bromoergokryptine,CB 154,CB154,Mesylate, 2-Bromoergocryptine,Mesylate, Bromocriptine,Methanesulfonate, 2-Bromoergocryptine
D005260 Female Females
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D005640 Follicle Stimulating Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Follicle-stimulating hormone stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and LEYDIG CELLS. FSH consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity. FSH (Follicle Stimulating Hormone),Follicle-Stimulating Hormone,Follitropin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G K Osbourne, and K A Whigham, and P W Howie, and P England, and A Kelly, and C R Prentice
September 1996, Acta obstetricia et gynecologica Scandinavica,
G K Osbourne, and K A Whigham, and P W Howie, and P England, and A Kelly, and C R Prentice
September 1975, British journal of obstetrics and gynaecology,
G K Osbourne, and K A Whigham, and P W Howie, and P England, and A Kelly, and C R Prentice
December 1996, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
G K Osbourne, and K A Whigham, and P W Howie, and P England, and A Kelly, and C R Prentice
January 1996, Journal of endocrinological investigation,
G K Osbourne, and K A Whigham, and P W Howie, and P England, and A Kelly, and C R Prentice
June 1993, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
G K Osbourne, and K A Whigham, and P W Howie, and P England, and A Kelly, and C R Prentice
October 1985, Ginekologia polska,
G K Osbourne, and K A Whigham, and P W Howie, and P England, and A Kelly, and C R Prentice
May 1978, Endokrinologie,
G K Osbourne, and K A Whigham, and P W Howie, and P England, and A Kelly, and C R Prentice
June 1980, The Journal of clinical endocrinology and metabolism,
G K Osbourne, and K A Whigham, and P W Howie, and P England, and A Kelly, and C R Prentice
November 1988, Obstetrics and gynecology,
G K Osbourne, and K A Whigham, and P W Howie, and P England, and A Kelly, and C R Prentice
January 1980, Journal of endocrinological investigation,
Copied contents to your clipboard!